235 related articles for article (PubMed ID: 24859383)
1. Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.
Nam JH; Leem E; Jeon MT; Jeong KH; Park JW; Jung UJ; Kholodilov N; Burke RE; Jin BK; Kim SR
Mol Neurobiol; 2015 Apr; 51(2):487-99. PubMed ID: 24859383
[TBL] [Abstract][Full Text] [Related]
2. In vivo AAV1 transduction with hRheb(S16H) protects hippocampal neurons by BDNF production.
Jeon MT; Nam JH; Shin WH; Leem E; Jeong KH; Jung UJ; Bae YS; Jin YH; Kholodilov N; Burke RE; Lee SG; Jin BK; Kim SR
Mol Ther; 2015 Mar; 23(3):445-55. PubMed ID: 25502903
[TBL] [Abstract][Full Text] [Related]
3. Activation of CNTF/CNTFRα signaling pathway by hRheb(S16H) transduction of dopaminergic neurons in vivo.
Jeong KH; Nam JH; Jin BK; Kim SR
PLoS One; 2015; 10(3):e0121803. PubMed ID: 25799580
[TBL] [Abstract][Full Text] [Related]
4. Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease.
Leem E; Nam JH; Jeon MT; Shin WH; Won SY; Park SJ; Choi MS; Jin BK; Jung UJ; Kim SR
J Nutr Biochem; 2014 Jul; 25(7):801-6. PubMed ID: 24797334
[TBL] [Abstract][Full Text] [Related]
5. Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo.
Kim S; Moon GJ; Oh YS; Park J; Shin WH; Jeong JY; Choi KS; Jin BK; Kholodilov N; Burke RE; Kim HJ; Ha CM; Lee SG; Kim SR
Exp Mol Med; 2018 Feb; 50(2):e440. PubMed ID: 29422542
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
8. AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth.
Kim SR; Kareva T; Yarygina O; Kholodilov N; Burke RE
Mol Ther; 2012 Feb; 20(2):275-86. PubMed ID: 22008911
[TBL] [Abstract][Full Text] [Related]
9. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
11. Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons
Jeon MT; Kim SR
Biomed Rep; 2015 Mar; 3(2):137-140. PubMed ID: 25798236
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.
Jeon MT; Moon GJ; Kim S; Choi M; Oh YS; Kim DW; Kim HJ; Lee KJ; Choe Y; Ha CM; Jang IS; Nakamura M; McLean C; Chung WS; Shin WH; Lee SG; Kim SR
Br J Pharmacol; 2020 Feb; 177(3):668-686. PubMed ID: 31658360
[TBL] [Abstract][Full Text] [Related]
13. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R
Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244
[TBL] [Abstract][Full Text] [Related]
16. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
17. Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.
Peng C; Aron L; Klein R; Li M; Wurst W; Prakash N; Le W
J Neurosci; 2011 Sep; 31(36):12802-15. PubMed ID: 21900559
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease.
Chun HS; Son JJ; Son JH
Neuroreport; 2000 Feb; 11(3):511-4. PubMed ID: 10718305
[TBL] [Abstract][Full Text] [Related]
19. Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus
Yun D; Jeon MT; Kim HJ; Moon GJ; Lee S; Ha CM; Shin M; Kim SR
Exp Neurobiol; 2020 Apr; 29(2):164-175. PubMed ID: 32408406
[TBL] [Abstract][Full Text] [Related]
20. Treatment with AAV1-Rheb(S16H) provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke.
Yoon D; Jeon MT; Dong Woon K; Kim SR
Neuroreport; 2020 Sep; 31(13):971-978. PubMed ID: 32694311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
